* CDC says 10 million more doses of vaccine available
* FDA to allow Roche to release reserve of Tamiflu (Adds details from CDC)
CHICAGO, Jan 18 (Reuters) - Flu remains widespread in the United States and 29 children have died of complications from it, but there are signs the epidemic is easing, U.S. health officials said on Friday.
Forty-eight states reported widespread influenza infections last week, according to the U.S. Centers for Disease Control and Prevention.
CDC Director Dr. Tom Frieden described this year as a "worse than average season, particularly for the elderly."
"Many parts of the country are still seeing high - and in some parts - increasing levels of activity while overall activity is beginning to go down," Frieden said in a teleconference.
This year's flu season has reached the midpoint, which means new cases of flu are beginning to fall, but Frieden said he expects both the number and rates of hospitalization and death to rise further as the flu epidemic progresses.
Thousands of people die every year from flu, but the elderly generally are the hardest hit, with 90 percent of all flu deaths occurring in people over age 65.
The CDC does not keep track of all flu-related deaths in adults, but during the second week of January, 8.3 percent of deaths reported to its 122 Cities Mortality Reporting System were due to pneumonia and influenza. That is up from 7.3 percent reported the previous week and exceeds the epidemic threshold of 7.2 percent.
In the first two weeks of January, nine children died of complications from the flu, bringing the death toll of children from this year's flu season to 29, the CDC reported.
That compares with a total of 34 child deaths for the entire 2011-2012 flu season, an especially mild one, and 282 during the severe 2009-2010 season.
Last week, the percentage of visits to healthcare providers for flu-like illness fell to 4.6 percent, down from a revised 4.8 percent in the prior week, the CDC said. By comparison, in the 2009 H1N1 "swine" flu pandemic, 7.7 percent of visits were for flu-like illness.
Despite continued reports of spot shortages, Frieden said it is not too late to get vaccinated.
Flu vaccine makers had expected to produce 135 million doses of vaccine, but they have been able to eek out an additional 10 million doses. So far, Frieden said, 129 million doses have been made available for distribution to doctors' offices, drug stores, clinics and other facilities.
"That means there is more vaccine out there for suppliers to order," he said.
To avert shortages of the antiviral drug Tamiflu, made by Roche Holding AG's Genentech unit, Food and Drug Administration Commissioner Dr. Margaret Hamburg said her agency has authorized the company to distribute 2 million doses of a 75 milligram capsule from its stockpile that contains an older version of the package instructions.
"This medication is fully approved. It is not outdated," she said. "To assure people have access, we took the necessary steps to allow Genentech to distribute its reserve without requiring them to repackage it, which would have taken months," Hamburg said.
Last week, Roche said the liquid form of Tamiflu, which is given to children who already have the flu to alleviate symptoms, was in short supply.
At the time, Roche said it had warned wholesalers and distributors that temporary delays in shipments were imminent.
Pharmacists can make a substitute by dissolving Tamiflu capsules in a sweet liquid.
(Reporting by Julie Steenhuysen; Editing by Vicki Allen and Eric Beech)
Our 2024 Coverage Needs You
It's Another Trump-Biden Showdown — And We Need Your Help
The Future Of Democracy Is At Stake
Our 2024 Coverage Needs You
Your Loyalty Means The World To Us
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
The 2024 election is heating up, and women's rights, health care, voting rights, and the very future of democracy are all at stake. Donald Trump will face Joe Biden in the most consequential vote of our time. And HuffPost will be there, covering every twist and turn. America's future hangs in the balance. Would you consider contributing to support our journalism and keep it free for all during this critical season?
HuffPost believes news should be accessible to everyone, regardless of their ability to pay for it. We rely on readers like you to help fund our work. Any contribution you can make — even as little as $2 — goes directly toward supporting the impactful journalism that we will continue to produce this year. Thank you for being part of our story.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
It's official: Donald Trump will face Joe Biden this fall in the presidential election. As we face the most consequential presidential election of our time, HuffPost is committed to bringing you up-to-date, accurate news about the 2024 race. While other outlets have retreated behind paywalls, you can trust our news will stay free.
But we can't do it without your help. Reader funding is one of the key ways we support our newsroom. Would you consider making a donation to help fund our news during this critical time? Your contributions are vital to supporting a free press.
Contribute as little as $2 to keep our journalism free and accessible to all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. Would you consider becoming a regular HuffPost contributor?
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. If circumstances have changed since you last contributed, we hope you'll consider contributing to HuffPost once more.
Support HuffPostAlready contributed? Log in to hide these messages.